The Street’s Key Stock Analysts Research Reports

The Street’s Key Stock Analysts Research Reports


Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new tradingand investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of the Street’s Key analysts outlook for main issues for Thursday, as follows:

Cardiovascular Systems Inc. (NASDAQ:CSII) was started with a Buy rating and assigned a 45 price target at Stifel.

CenturyLink Inc. (NYSE:CTL) was downgraded to Sell from Neutral with a 19 price target at MoffattNathanson. Its consensus target price was 21.28, and it has a 52-wk trading range of 13.16 to 24.20.

Itron Inc. (NASDAQ:ITRI) was raised to Buy from Hold with a 72 price target at Argus.

Finisar Inc. (NASDAQ:FNSR) was downgraded to Market Perform from Outperform at Raymond James.

Laboratory Corp. of America Holdings (NYSE:LH) was reiterated as Buy with a target price of 202 at Argus.

Landstar Systems Inc. (NASDAQ: LSTR) was raised to Outperform from Market Perform with a 133 price target at Wells Fargo.

MercadoLibre Inc. (NASDAQ: MELI) was raised to Buy from Hold with a 380 price target at Stifel.

Netflix Inc. (NASDAQ:NFLX) was reiterated as Buy and the price target was raised to 395 from 390 at MKM Partners. The team is calling for 90-M US subscribers and 300-M international subscribers by Y 2025.

Nightstar Therapeutics PLC (NASDAQ:NITE) was started with a Buy rating and assigned a 34 price target at Janney. The firm called Nightstar a leader in gene therapy for inherited retinal disorders.

YRC Worldwide Inc. (NASDAQ: YRCW) was raised to Buy from Hold at Deutsche Bank. The 52-wk trading range is 8.07 – 17.61

Stay tuned…

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

You must be logged in to post comments :